CompletedInterventionalPhase 4Updated Nov 30, 2018
CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy | NCT00836017 | Trialant
CompletedObservationalUpdated Jul 17, 2014
CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy
ClinicalTrials.gov ID
NCT00836017
Lead Sponsor
AllerganINDUSTRY
Overall Status
Completed
Study Type
Observational
Enrollment
1,046Actual
Last Update Posted
Jul 17, 2014Estimated
Start Date
Jan 2009
Primary Completion Date
Aug 2013Actual
Completion Date
Aug 2013Actual
Brief Summary
This study is an observational trial which will measure the efficacy of onabotulinumtoxinA in treating Cervical Dystonia.
Cervical Dystonia
No Intervention
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosed with Cervical Dystonia
Candidate for botulinum toxin type A therapy
New to physician's practice, and/or new to botulinum toxin type A therapy, or has not been injected with botulinum toxin type A for at least 16 weeks as a participant in another clinical trial investigating botulinum toxin type A for cervical dystonia
Able to follow study instructions and complete study activities
Exclusion Criteria:
Patients undergoing elective surgery during the trial period
Females who are pregnant, nursing, or planning a pregnancy
History of poor cooperation or compliance with medical treatment or unreliability
Any condition or situation in which, in the investigator's opinion, places the patient at significant risk, could confound the study data, or may interfere with the patient's participation in the study, including but not limited to unstable medical conditions